Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Articles

Review

Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective

Clinical and Molecular Hepatology 2021;27(1):44-57.
Published online: November 19, 2020

1Department of Pathology, National University Hospital, Singapore, Singapore

2Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Corresponding author : Aileen Wee Department of Pathology, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074, Singapore Tel: +65-67724305, Fax: +65-67780671 E-mail: aileen_wee@nuhs.edu.sg

Editor: Han Ah Lee, Korea University College of Medicine, Korea

• Received: July 20, 2020   • Revised: August 25, 2020   • Accepted: August 26, 2020

Copyright © 2021 by The Korean Association for the Study of the Liver

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 24,744 Views
  • 426 Download
  • 57 Web of Science
  • 62 Crossref
  • 55 Scopus
prev next

Citations

Citations to this article as recorded by  Crossref logo
  • The Elucidating Pathways of Steatohepatitis (EPoS) staging system: A reproducible 7-tiered fibrosis scoring system in MASLD
    Dina G. Tiniakos, Pierre Bedossa, Johanna Arola, Susan Davies, Annette S.H. Gouw, Maria Guido, Carolin Lackner, Peter Schirmacher, Luigi Terracciano, Alasdair Blain, Kristy Wonders, Quentin M. Anstee, Vlad Ratziu, Valerie Paradis
    JHEP Reports.2026; 8(4): 101737.     CrossRef
  • S100A10-ANXA2 tetramer inhibition hampers hepatic stellate cell activation in human MASLD organoids
    Miranda Türkal, Christine Maeder, Marta Correia de Sousa, Margot Fournier, Sanae El-Harane, Monika Gjorgjieva, Michelangelo Foti, Pierre Maechler, Etienne Delangre
    EMBO Molecular Medicine.2026; 18(7): 2920.     CrossRef
  • Fibroblast- and Macrophage-Derived Thrombospondin-1 Orchestrates the Fibroinflammatory Niche in Metabolic Dysfunction-Associated Steatohepatitis-Induced Fibrosis
    Sung Woo Cho, Jung Hoon Cha, Deok Wha Seo, Mi Hyun Kwon, Kwon Yong Tak, Hee Sun Cho, Keungmo Yang, Seo Young Jung, SuHyun Hwangbo, Jae Yong Ryu, Si Hyun Bae, Pil Soo Sung
    Diabetes & Metabolism Journal.2026;[Epub]     CrossRef
  • An Optimized Freeze‐Dry Multimodal Workflow for Sequential Micro‐CT Imaging, Histology, and Molecular Profiling: A Use Case in Human Liver Fibrosis
    Kristijan Skok, Laura Činč Ćurić, Jernej Vajda, Silvia Schauer, Martin Wagner, Rudolf Stauber, Carolin Lackner, Karl Kashofer, Markus Plass, Giovanny Rodriguez Blanco, Ian R. Wanless, Uroš Maver, Katrin Panzitt, Boštjan Vihar
    Advanced Science.2026;[Epub]     CrossRef
  • Extracellular Volume Fraction Imaging for Hepatic Fibrosis: CT and MRI Implementation and Evidence
    Jialin Qi, Yubo Chi, Weiling Xu, Jingyu Wang
    Academic Radiology.2026; 33(10): 4235.     CrossRef
  • Predictive Analysis on the Mechanism of Dendrobium officinale Polysaccharides in Treating Hepatic Fibrosis via Network Pharmacology and Molecular Docking
    Liu Xuwei, Fan Qin, Lou Suyue, Yang Liuqing, Bai Yajie, Jia Jingwen, Wang Zhirun, Jiang Xuezhi, Cheng Jiamao, Chen Haiyan
    BioMed Research International.2026;[Epub]     CrossRef
  • Realizing personalized prediction for the reversal of chronic hepatitis B-associated liver fibrosis through machine learning
    Shi-Cai Liu, Zi-Wen Wang, Han Zhang
    World Journal of Gastroenterology.2026;[Epub]     CrossRef
  • Non-invasive evaluation of early liver fibrosis process by targeting αvβ6 integrin PET imaging
    Shuang Yan, Wenxuan Qiu, Yangye Tie, Wanlu Feng, Jinghui Qin, Huanyu Chen, Yu Zhang, Jie Zeng, Li Wang
    Biochemical Pharmacology.2026; 254: 118494.     CrossRef
  • Maladaptive Liver Regeneration in Chronic Liver Disease: Cellular Mechanisms Linking Ductular Reaction, Parenchymal Extinction, and Extracellular Matrix Remodelling
    Martyna Szymonik, Nadzieja Krasucka, Milena Krupa, Dominika Małek, Julia Płaza-Kościańczuk, Jakub Kleinrok, Weronika Pająk, Kamil Rusztyn, Maciej Mazur, Agnieszka Korolczuk
    Journal of Personalized Medicine.2026; 16(10): 526.     CrossRef
  • Machine learning-based segmentation and quantitative histological assessment of bovine liver fibrosis: Comparative performance of three open-source models
    Omar Younis Altaey, Shahbaa Khalil AL-Taee, Saffanah Khuder Mahmood, Ghada Abdulrahman Sultan
    Veterinary World.2026; : 4641.     CrossRef
  • Pixel classifier-based image analysis of metabolic dysfunction–associated steatohepatitis in mice
    Yao Lee, Ingrid L. Bergin, Neil B. Blok, Andriy Myronovych, Garrett McMahon, Randy J. Seeley, Nadejda Bozadjieva-Kramer
    Veterinary Pathology.2026;[Epub]     CrossRef
  • Quantitative fibrosis identifies biliary tract involvement and is associated with outcomes in pediatric autoimmune liver disease
    Leticia Khendek, Cyd Castro-Rojas, Constance Nelson, Mosab Alquraish, Rebekah Karns, Jennifer Kasten, Xiao Teng, Alexander G. Miethke, Amy E. Taylor
    Hepatology Communications.2025;[Epub]     CrossRef
  • A comparative study on the effect of melatonin and orlistat combination versus orlistat alone on high fat diet-induced hepatic changes in the adult male albino rats (a histological and morphometric study)
    Sayed M. El-Sayed, Gehan A. El-Sayed, Mansour M.A, Enas Haridy Ahmed, Sherif A. Kamar
    Ultrastructural Pathology.2025; 49(1): 20.     CrossRef
  • Revolutionizing MASLD: How Artificial Intelligence Is Shaping the Future of Liver Care
    Nicola Pugliese, Arianna Bertazzoni, Cesare Hassan, Jörn M. Schattenberg, Alessio Aghemo
    Cancers.2025; 17(5): 722.     CrossRef
  • Extracellular Matrix Microstructures Modulate Hepatic Methionine Cycle and Methylations
    John A. Terrell, Chengpeng Chen
    Biomacromolecules.2025; 26(6): 3356.     CrossRef
  • Assessing the diagnostic accuracy of ChatGPT-4 in the histopathological evaluation of liver fibrosis in MASH
    Davide Panzeri, Thiyaphat Laohawetwanit, Reha Akpinar, Camilla De Carlo, Vincenzo Belsito, Luigi Terracciano, Alessio Aghemo, Nicola Pugliese, Giuseppe Chirico, Donato Inverso, Julien Calderaro, Laura Sironi, Luca Di Tommaso
    Hepatology Communications.2025;[Epub]     CrossRef
  • Phosphocreatine alleviates liver fibrosis in diabetic mice by targeting TGF-β/Smad and α-SMA pathways
    Fu Han Wang, Eskandar Qaed, Waleed Aldahmash, Mueataz A. Mahyoub, Dalal Sanad Al-Mutairi, Zeyao Tang, Marwan almoiliqy
    Tissue and Cell.2025; 96: 103013.     CrossRef
  • Proof of Concept: Super‐Resolution Ultrasound and Viscoelastic Imaging of Hepatic Microcirculation for Early Detection and Staging of Liver Fibrosis in a Murine Model
    Rui Zhang, Jieqiong Wang, Tingting Liu, Yan Wang, Shuai Yang, Fei Yan, Li Xue
    Journal of Ultrasound in Medicine.2025; 44(8): 1481.     CrossRef
  • Leveraging artificial intelligence to validate traditional biomarkers and drug targets in liver cancer recovery: a mini review
    Shengjian Wu, Xiaoqiao Chen, Yuxiu Ji, Chi Zhang, Yujie Xie, Bin Liang
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Emerging role of artificial intelligence in gastroenterology and hepatology
    Umid K Shrestha
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Liver biopsy in the modern era: from traditional techniques to artificial intelligence and multi-omics integration
    Nasar Alwahaibi, Maryam Alwahaibi
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • The expression of OX40 in CD4+ T cells and its association with hepatic fibrosis injury
    YaLing Xu, WenNa Li, Yuan Li, Xin Li, XinNa Li, Bo Wang
    Immunobiology.2025; 230(6): 153143.     CrossRef
  • Quantitative Analysis of Liver Fibrosis Expansion Using 3D-Reconstructed Stained Images and Statistical Modeling
    Ryoma Ueda, Hiroto Shoji
    FORMA.2025; 40(1): 21.     CrossRef
  • The prediction of liver decompensation using hepatic collagen deposition assessed by computer-assisted image analysis with Masson’s trichrome stain
    Hae Won Yoo, Jae Woo Park, Min Jung Jung, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim
    Scandinavian Journal of Gastroenterology.2024; 59(1): 85.     CrossRef
  • Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions
    Vlad Ratziu, Marcus Hompesch, Mathieu Petitjean, Cindy Serdjebi, Janani S. Iyer, Anil V. Parwani, Dean Tai, Elisabetta Bugianesi, Kenneth Cusi, Scott L. Friedman, Eric Lawitz, Manuel Romero-Gómez, Detlef Schuppan, Rohit Loomba, Valérie Paradis, Cynthia Be
    Journal of Hepatology.2024; 80(2): 335.     CrossRef
  • AI Digital Pathology Using qFibrosis Shows Heterogeneity of Fibrosis Regression in Patients with Chronic Hepatitis B and C with Viral Response
    Feng Liu, Yameng Sun, Dean Tai, Yayun Ren, Elaine L. K. Chng, Aileen Wee, Pierre Bedossa, Rui Huang, Jian Wang, Lai Wei, Hong You, Huiying Rao
    Diagnostics.2024; 14(16): 1837.     CrossRef
  • Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model
    Radina Kostadinova, Simon Ströbel, Li Chen, Katia Fiaschetti‑Egli, Jana Gadient, Agnieszka Pawlowska, Louis Petitjean, Manuela Bieri, Eva Thoma, Mathieu Petitjean
    Scientific Reports.2024;[Epub]     CrossRef
  • Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities
    Eugene Han, Yong-ho Lee, Sang Hoon Ahn, Bong-Soo Cha, Seung Up Kim, Byung-Wan Lee
    Gut and Liver.2024; 18(3): 509.     CrossRef
  • Potential role of predictive models in assessment of liver inflammation in patients with hepatocellular carcinoma: a two-center cohort study
    Wei Xu, Bolun Li, Huai Gong, Jingdong Li, Zhanwei Yang, Yu Liu
    European Journal of Medical Research.2024;[Epub]     CrossRef
  • NAFLD, MAFLD and obesity: brothers in arms?
    Mariana Verdelho Machado, Helena Cortez-Pinto
    Nature Reviews Gastroenterology & Hepatology.2023; 20(2): 67.     CrossRef
  • Effect of exercise-based interventions in nonalcoholic fatty liver disease: A systematic review with meta-analysis
    Heechul Nam, Jeong-Ju Yoo, Yuri Cho, Seong Hee Kang, Sang Bong Ahn, Hye-Won Lee, Dae Won Jun, Do Seon Song, Miyoung Choi
    Digestive and Liver Disease.2023; 55(9): 1178.     CrossRef
  • Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
    Seung Min Lee, Dae Won Jun
    Clinical and Molecular Hepatology.2023; 29(1): 171.     CrossRef
  • Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial
    Arun J. Sanyal, Patricia Lopez, Eric J. Lawitz, Kathryn J. Lucas, Juergen Loeffler, Won Kim, George B. B. Goh, Jee-Fu Huang, Carla Serra, Pietro Andreone, Yi-Cheng Chen, Stanley H. Hsia, Vlad Ratziu, Diego Aizenberg, Hiroshi Tobita, Aasim M. Sheikh, John
    Nature Medicine.2023; 29(2): 392.     CrossRef
  • Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
    Tina Reinson, Ryan M. Buchanan, Christopher D. Byrne
    Clinical and Molecular Hepatology.2023; 29(Suppl): S157.     CrossRef
  • Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
    Jung Hwan Yu, Han Ah Lee, Seung Up Kim
    Clinical and Molecular Hepatology.2023; 29(Suppl): S136.     CrossRef
  • Screening strategy for non-alcoholic fatty liver disease
    Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
    Clinical and Molecular Hepatology.2023; 29(Suppl): S103.     CrossRef
  • Non-alcoholic fatty liver disease: Definition and subtypes
    Seul Ki Han, Soon Koo Baik, Moon Young Kim
    Clinical and Molecular Hepatology.2023; 29(Suppl): S5.     CrossRef
  • Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
    Terry Cheuk-Fung Yip, Fei Lyu, Huapeng Lin, Guanlin Li, Pong-Chi Yuen, Vincent Wai-Sun Wong, Grace Lai-Hung Wong
    Clinical and Molecular Hepatology.2023; 29(Suppl): S171.     CrossRef
  • Artificial intelligence and deep learning: New tools for histopathological diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato
    Computational and Structural Biotechnology Journal.2023; 21: 2495.     CrossRef
  • Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI‐PDFF in NAFLD
    Beom K. Kim, Nicole Bernstein, Daniel Q. Huang, Nobuharu Tamaki, Kento Imajo, Masato Yoneda, Nancy Sutter, Jinho Jung, Khang Nguyen, Leyna Nguyen, Tracy Le, Egbert Madamba, Lisa Richards, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi Nakajim
    Alimentary Pharmacology & Therapeutics.2023; 58(2): 229.     CrossRef
  • Diagnóstico, tratamiento y complicaciones actualizadas de la enfermedad de hígado graso no alcohólico
    Nicole Estefanía Rivadeneira Poveda, Verónica Cristina Jurado Melo
    Anatomía Digital.2023; 6(1.2): 6.     CrossRef
  • Artifacts in two-dimensional shear wave elastography of liver
    Hui-Peng Wang, Peng-Chao Zheng, Xue-Mei Wang, Liang Sang
    World Journal of Gastroenterology.2023; 29(21): 3318.     CrossRef
  • Low‐quality muscle mass rather than normal‐quality muscle mass determines fibrosis progression in biopsy‐proven NAFLD
    Yun Kyu Lee, Bo Kyung Koo, Sae Kyung Joo, Dong Hyeon Lee, Heejoon Jang, Jee Won Chai, Myoung Seok Lee, Si Won Jang, Young Ho So, Jeong Hwan Park, Mee Soo Chang, Won Kim
    Alimentary Pharmacology & Therapeutics.2023; 58(3): 322.     CrossRef
  • Transient elastography with controlled attenuation parameter versus two-dimensional shear wave elastography with attenuation imaging for the evaluation of hepatic steatosis and fibrosis in NAFLD
    Jung Wook Seo, Youe Ree Kim, Jong Keon Jang, So Yeon Kim, Young Youn Cho, Eun Sun Lee, Dong Ho Lee
    Ultrasonography.2023; 42(3): 421.     CrossRef
  • AutoFibroNet: A deep learning and multi‐photon microscopy‐derived automated network for liver fibrosis quantification in MAFLD
    Huiling Zhan, Siyu Chen, Feng Gao, Guangxing Wang, Sui‐Dan Chen, Gangqin Xi, Hai‐Yang Yuan, Xiaolu Li, Wen‐Yue Liu, Christopher D. Byrne, Giovanni Targher, Miao‐Yang Chen, Yong‐Feng Yang, Jun Chen, Zhiwen Fan, Xitai Sun, Guorong Cai, Ming‐Hua Zheng, Shuan
    Alimentary Pharmacology & Therapeutics.2023; 58(6): 573.     CrossRef
  • Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes
    Tae Seop Lim, Ho Soo Chun, Soon Sun Kim, Ja Kyung Kim, Minjong Lee, Hyo Jung Cho, Seung Up Kim, Jae Youn Cheong
    Gut and Liver.2023; 17(4): 610.     CrossRef
  • Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients
    Mi Na Kim, Kyungdo Han, Juhwan Yoo, Seong Gyu Hwang, Xuehong Zhang, Sang Hoon Ahn
    International Journal of Cancer.2023; 153(8): 1448.     CrossRef
  • Serum IL-27 levels increase in subjects with hypothyroidism and are negatively correlated with the occurrence of nonalcoholic fatty liver disease
    Yahui Wen, Heng Zhang, Ning Yang, Xia Gao, Zhe Chen, Jia Liu, Guang Wang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study
    Beom Kyung Kim, Jaclyn Bergstrom, Rohan Loomba, Nobuharu Tamaki, Namiki Izumi, Atsushi Nakajima, Ramazan Idilman, Mesut Gumussoy, Digdem K. Oz, Ayse Erden, Emily Truong, Ju Dong Yang, Mazen Noureddin, Alina M. Allen, Rohit Loomba, Veeral Ajmera
    Hepatology.2023; 78(6): 1858.     CrossRef
  • Diagnosis of liver fibrosis using digital analysis
    Anna Kleczka, Bogdan Mazur, Krzysztof Tomaszek, Radosław Dzik, Agata Kabała-Dzik
    Diagnostyka Laboratoryjna.2023; 59(2): 65.     CrossRef
  • Noninvasive surrogates are poor predictors of liver fibrosis in patients with Fontan circulation
    Yu Rim Shin, Seung Up Kim, Sak Lee, Jae Young Choi, Han Ki Park, Jeong Eun Yoo, Young Nyun Park
    The Journal of Thoracic and Cardiovascular Surgery.2022; 164(4): 1176.     CrossRef
  • Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
    Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Jae Young Jang, Soo Young Park, Hyun Woong Lee, Chun Kyon Lee, Seung Up Kim
    Frontiers in Medicine.2022;[Epub]     CrossRef
  • Digital pathology with artificial intelligence analyses provides greater insights into treatment-induced fibrosis regression in NASH
    Nikolai V. Naoumov, Dominique Brees, Juergen Loeffler, Elaine Chng, Yayun Ren, Patricia Lopez, Dean Tai, Sophie Lamle, Arun J. Sanyal
    Journal of Hepatology.2022; 77(5): 1399.     CrossRef
  • The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
    Haofei Hu, Yong Han, Changchun Cao, Yongcheng He
    Journal of Translational Medicine.2022;[Epub]     CrossRef
  • Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD
    Beom Kyung Kim, Nobuharu Tamaki, Kento Imajo, Masato Yoneda, Nancy Sutter, Jinho Jung, Tuo Lin, Xin M. Tu, Jaclyn Bergstrom, Khang Nguyen, Leyna Nguyen, Tracy Le, Egbert Madamba, Lisa Richards, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi N
    Journal of Hepatology.2022; 77(6): 1482.     CrossRef
  • Magnetic resonance imaging improves stratification of fibrosis and steatosis in patients with chronic liver disease
    Han Ah Lee, Seung-seob Kim, Jin-Young Choi, Yeon Seok Seo, Beom Jin Park, Ki Choon Sim, Seung Up Kim
    Abdominal Radiology.2022; 47(11): 3733.     CrossRef
  • Rethinking Liver Fibrosis Staging in Patients with Hepatocellular Carcinoma: New Insights from a Large Two-Center Cohort Study
    Wei Xu, Bolun Li, Zhanwei Yang, Jingdong Li, Fei Liu, Yu Liu
    Journal of Hepatocellular Carcinoma.2022; Volume 9: 751.     CrossRef
  • Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
    Ludovico Abenavoli, Tiziana Larussa, Alessandro Corea, Anna Caterina Procopio, Luigi Boccuto, Marcello Dallio, Alessandro Federico, Francesco Luzza
    Nutrients.2021; 13(2): 494.     CrossRef
  • The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics
    James Neuberger, Owen Cain
    Hepatic Medicine: Evidence and Research.2021; Volume 13: 59.     CrossRef
  • Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease
    Hee Kyung Shin, Jeong Hwan Park, Jung Hwan Yu, Young-Joo Jin, Young Ju Suh, Jin-Woo Lee, Won Kim
    Scientific Reports.2021;[Epub]     CrossRef
  • Predict Early Recurrence of Resectable Hepatocellular Carcinoma Using Multi-Dimensional Artificial Intelligence Analysis of Liver Fibrosis
    I-Ting Liu, Chia-Sheng Yen, Wen-Lung Wang, Hung-Wen Tsai, Chang-Yao Chu, Ming-Yu Chang, Ya-Fu Hou, Chia-Jui Yen
    Cancers.2021; 13(21): 5323.     CrossRef
  • Maternal Western diet exposure increases periportal fibrosis beginning in utero in nonhuman primate offspring
    Michael J. Nash, Evgenia Dobrinskikh, Sean A. Newsom, Ilhem Messaoudi, Rachel C. Janssen, Kjersti M. Aagaard, Carrie E. McCurdy, Maureen Gannon, Paul Kievit, Jacob E. Friedman, Stephanie R. Wesolowski
    JCI Insight.2021;[Epub]     CrossRef

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
Clin Mol Hepatol. 2021;27(1):44-57.   Published online November 19, 2020
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:
Include:
Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
Clin Mol Hepatol. 2021;27(1):44-57.   Published online November 19, 2020
Close

Figure

  • 0
  • 1
Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
Image Image
Figure 1. Comparison of histopathological staining (H&E and Masson trichrome) with SHG/TPEF images of liver biopsy tissue from NAFLD patients. SHG imaging, Masson trichrome, and H&E were performed on serial sections (×200). H&E, haemotoxylin and eosin; SHG, second harmonic generation; TPEF, two-photon excitation fluorescence; NAFLD, nonalcoholic fatty liver disease.
Figure 2. Comparison of the various noninvasive and invasive methods for fibrosis assessment in terms of the quantitative and qualitative information yielded. The size of the circle represents current utility in clinical practice/trials (shaded area represents potential growth). CPA, collagen proportionate area; TE, transient elastography; MRE, magnetic resonance elastography; SHG, second harmonic generation.
Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
Fibrosis stage Brunt system [53] NASH CRN score [48] SAF score [57]
0 None None None
1 Zone 3 perisinusoidal fibrosis; focally or extensively present 1a: Mild (delicate) zone 3 perisinusoidal fibrosis
1b: Moderate (dense) zone 3 perisinusoidal fibrosis
1c: Portal fibrosis only
2 Zone 3 perisinusoidal fibrosis with focal or extensive periportal fibrosis Zone 3 perisinusoidal fibrosis with periportal fibrosis
3 Zone 3 perisinusoidal fibrosis and portal fibrosis with focal or extensive bridging fibrosis Bridging fibrosis
4 Cirrhosis Cirrhosis
Study Model Methodology No. of patients Performance
Wang et al. [79] (2017) q-FP SHG/TPEF to capture images (of whole biopsy section) 50 (test cohort) Principal component analysis model of 16 q-FPs:
Images assessed with computerized image-analysis by two independent investigators to output the profile of q-FPs data for each slice in operator-defined segmentation regions of liver tissue, including: 42 (validation cohort) - Fibrosis vs. no fibrosis: AUC 0.88
(1) General: the liver section in its entirety - Cirrhosis vs. earlier stages: AUC 0.93
(2) Perisinusoidal: hepatocyte-associated collagen in the perisinusoidal space Linear scale of fibrosis measurement of 4 q-FPs using desirability functions:
(3) Vessel: collagen fibrils directly connected to veins; and - Related to fibrosis stage (P<0.0001)
(4) Vessel bridges: collagen fibrils extending from vein to vein or vein to portal tract.
70 q-FPs had interclass concordance ≥0.8 which were selected for further model development
Wang et al. [81] (2020) q-FP Compared against NASH CRN staging system (but with substages of stage 1 combined) 344 (428 biopsies) (larger validation study) 25 q-FPs with AUC >0.90 for different fibrosis stages; perimeter of collagen fibres and number of long collagen fibres had the best accuracy (88.3–96.2% sensitivity and 78.1–91.1% specificity for different fibrosis stages)
Chang et al. [76] (2018) SHG B-index SHG/TPEF to capture images (final sampling size of 10 mm2 per biopsy) 83 adults Prediction model based on 14 unique SHG-based collagen parameters
An image processing algorithm was used to quantify fibrosis features in three specific regions: 1) central vein, 2) portal tract, and 3) perisinusoidal - Fibrosis vs. no fibrosis: AUC 0.853
In total, 100 collagen features were extracted and quantified, of which 28 features including the percentages of different collagen patterns and collagen string features were extracted in each region - Cirrhosis vs. earlier stages: AUC 0.941
- Stage 0/1 vs. 2/3/4: AUC 0.967
- Stage 0/1/2 vs. 3/4: AUC 0.985
Compared against Brunt’s staging system - High correlation of 0.820 with fibrosis stage (P<0.001)
Liu et al. [77] (2017) qFibrosis SHG/TPEF to capture images (final sampling size of 10 mm2 per biopsy) 62 adults (30 training, 32 validation); 36 children (18 training, 18 validation) Prediction model based on six shared parameters for string collagen
An image processing algorithm was used to quantify fibrosis features in three specific regions: 1) central vein, 2) portal tract, and 3) perisinusoidal (Adult)
- Fibrosis vs. no fibrosis: AUC 0.835
In total, 100 collagen features were extracted and quantified - Cirrhosis vs. earlier stages: 0.982
- Stage 0/1 vs. 2/3/4: AUC 0.892
- Stage 0/1/2 vs. 3/4: AUC 0.87
(Pediatric)
- Fibrosis vs. no fibrosis: AUC 0.981
- Stage 0/1 vs. 2/3: AUC 0.931
- Stage 0/1/2 vs. 3: AUC 0.885
Liu et al. [82] (2020) qFibrosis Compared against NASH CRN staging system 219 adults (146 training, 73 validation) (multicenter) Prediction model based on 17 parameters, with output as a numerical index from 0 and 6.55
- Fibrosis vs. no fibrosis: AUC 0.87
- Cirrhosis vs. earlier stages: 0.951
- Stage 0/1 vs. 2/3/4: AUC 0.881
- Stage 0/1/2 vs. 3/4: AUC 0.945
Table 1. Comparison of histological fibrosis scoring systems

NASH CRN, Nonalcoholic Steatohepatitis Clinical Research Network; SAF, steatosis activity fibrosis.

Table 2. Performance of SHG-based models for quantitative assessment of liver fibrosis in NAFLD

SHG, second harmonic generation; NAFLD, nonalcoholic fatty liver disease; q-FP, quantification of fibrosis-related parameter; TPEF, two-photon excitation fluorescence; AUC, area under curve; NASH CRN, Nonalcoholic Steatohepatitis Clinical Research Network.